Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls

OBJECTIVE: Recent studies have demonstrated an altered expression of certain microRNAs in patients with rheumatoid arthritis (RA) as well as their first-degree relatives (FDRs) compared to healthy controls (HCs), suggesting a role of microRNA in the progression of the disease. To corroborate this, a...

Full description

Bibliographic Details
Published in:Clinical Rheumatology
Main Authors: Renman, Emma, Brink, Mikael, Ärlestig, Lisbeth, Rantapää-Dahlqvist, Solbritt, Lejon, Kristina
Format: Text
Language:English
Published: Springer International Publishing 2020
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121735/
http://www.ncbi.nlm.nih.gov/pubmed/33210166
https://doi.org/10.1007/s10067-020-05502-9
id ftpubmed:oai:pubmedcentral.nih.gov:8121735
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:8121735 2023-05-15T17:44:58+02:00 Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls Renman, Emma Brink, Mikael Ärlestig, Lisbeth Rantapää-Dahlqvist, Solbritt Lejon, Kristina 2020-11-18 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121735/ http://www.ncbi.nlm.nih.gov/pubmed/33210166 https://doi.org/10.1007/s10067-020-05502-9 en eng Springer International Publishing http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121735/ http://www.ncbi.nlm.nih.gov/pubmed/33210166 http://dx.doi.org/10.1007/s10067-020-05502-9 © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . CC-BY Clin Rheumatol Original Article Text 2020 ftpubmed https://doi.org/10.1007/s10067-020-05502-9 2021-05-23T00:33:53Z OBJECTIVE: Recent studies have demonstrated an altered expression of certain microRNAs in patients with rheumatoid arthritis (RA) as well as their first-degree relatives (FDRs) compared to healthy controls (HCs), suggesting a role of microRNA in the progression of the disease. To corroborate this, a set of well-characterized RA families originating from northern Sweden were analyzed for differential expression of a selected set of microRNAs. METHOD: MicroRNA was isolated from frozen peripheral blood cells obtained from 21 different families and included 26 RA patients, 22 FDRs, and 21 HCs. Expression of the selected microRNAs miR-22-3p, miR-26b-5p, miR-34a-3p, miR-103a-3p, miR-142-3p, miR-146a-5p, miR-155, miR-346, and miR-451a was determined by a two-step quantitative real-time polymerase chain reaction (qRT-PCR). Statistical analysis including clinical variables was applied. RESULTS: Out of the nine selected microRNAs that previously have been linked to RA, we confirmed four after adjusting for age and gender, i.e., miR-22-3p (p = 0.020), miR-26b-5p (p = 0.018), miR-142-3p (p = 0.005), and miR-155 (p = 0.033). Moreover, a significant trend with an intermediate microRNA expression in FDR was observed for the same four microRNAs. In addition, analysis of the effect of corticosteroid use showed modulation of miR-103a-3p expression. CONCLUSIONS: We confirm that microRNAs seem to be involved in the development of RA, and that the expression pattern in FDR is partly overlapping with RA patients. The contribution of single microRNAs in relation to the complex network including all microRNAs and other molecules is still to be revealed. Text Northern Sweden PubMed Central (PMC) Clinical Rheumatology 40 6 2387 2394
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Original Article
spellingShingle Original Article
Renman, Emma
Brink, Mikael
Ärlestig, Lisbeth
Rantapää-Dahlqvist, Solbritt
Lejon, Kristina
Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
topic_facet Original Article
description OBJECTIVE: Recent studies have demonstrated an altered expression of certain microRNAs in patients with rheumatoid arthritis (RA) as well as their first-degree relatives (FDRs) compared to healthy controls (HCs), suggesting a role of microRNA in the progression of the disease. To corroborate this, a set of well-characterized RA families originating from northern Sweden were analyzed for differential expression of a selected set of microRNAs. METHOD: MicroRNA was isolated from frozen peripheral blood cells obtained from 21 different families and included 26 RA patients, 22 FDRs, and 21 HCs. Expression of the selected microRNAs miR-22-3p, miR-26b-5p, miR-34a-3p, miR-103a-3p, miR-142-3p, miR-146a-5p, miR-155, miR-346, and miR-451a was determined by a two-step quantitative real-time polymerase chain reaction (qRT-PCR). Statistical analysis including clinical variables was applied. RESULTS: Out of the nine selected microRNAs that previously have been linked to RA, we confirmed four after adjusting for age and gender, i.e., miR-22-3p (p = 0.020), miR-26b-5p (p = 0.018), miR-142-3p (p = 0.005), and miR-155 (p = 0.033). Moreover, a significant trend with an intermediate microRNA expression in FDR was observed for the same four microRNAs. In addition, analysis of the effect of corticosteroid use showed modulation of miR-103a-3p expression. CONCLUSIONS: We confirm that microRNAs seem to be involved in the development of RA, and that the expression pattern in FDR is partly overlapping with RA patients. The contribution of single microRNAs in relation to the complex network including all microRNAs and other molecules is still to be revealed.
format Text
author Renman, Emma
Brink, Mikael
Ärlestig, Lisbeth
Rantapää-Dahlqvist, Solbritt
Lejon, Kristina
author_facet Renman, Emma
Brink, Mikael
Ärlestig, Lisbeth
Rantapää-Dahlqvist, Solbritt
Lejon, Kristina
author_sort Renman, Emma
title Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_short Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_full Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_fullStr Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_full_unstemmed Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
title_sort dysregulated microrna expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
publisher Springer International Publishing
publishDate 2020
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121735/
http://www.ncbi.nlm.nih.gov/pubmed/33210166
https://doi.org/10.1007/s10067-020-05502-9
genre Northern Sweden
genre_facet Northern Sweden
op_source Clin Rheumatol
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121735/
http://www.ncbi.nlm.nih.gov/pubmed/33210166
http://dx.doi.org/10.1007/s10067-020-05502-9
op_rights © The Author(s) 2020
https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
op_rightsnorm CC-BY
op_doi https://doi.org/10.1007/s10067-020-05502-9
container_title Clinical Rheumatology
container_volume 40
container_issue 6
container_start_page 2387
op_container_end_page 2394
_version_ 1766147655192281088